Tag: dialysis
Quanta dialysis system receives US FDA clearance for home haemodialysis
Quanta Dialysis Technologies has confirmed the US Food and Drug Administration (FDA) has given 510(k) clearance for the use of its Quanta dialysis system...
Akebia Therapeutics and U.S. Renal Care sign commercial supply contract to...
Akebia Therapeutics and U.S. Renal Care (USRC) have recently announced entry into a multi-year commercial supply contract encompassing all USRC dialysis centres. The contract...
Invizius raises further funds for the development of “breakthrough” dialysis treatment
Invizius has just announced that it has raised £950,000 in a funding round led by Mercia Ventures and supported by Calculus Capital, Syensqo, the...
Renal Interventions’ top 10 stories of August 2024
August was a month of new research and reconsidering previously held notions, with a team from Stanford University School of Medicine (Palo Alto, USA)...
The NKF launches new online educational tool for people living with...
The National Kidney Foundation (NKF) has today launched NKF Patient Journey: Chronic Kidney Disease, a new interactive, online learning tool that it hopes will aid people living...
New research suggests dialysis may not be best option for elderly...
A new study recently published in Annals of Internal Medicine by lead author Maria Montez Rath, senior author Manjula Tamura (both Stanford University School...
Pre-emptive kidney transplantation could change lives and transform the transplant landscape
After taking part in a panel discussion at this year’s UK Kidney Association (UKKA) UK Kidney Week (UKKW; 11–13 June, Edinburgh, UK) that examined...
Pre-emptive kidney transplantation programme shown to be beneficial for patients
https://www.youtube.com/watch?v=SkM7wbRsEBU
At this year’s UK Kidney Association (UKKA) UK Kidney Week (UKKW) meeting (11–13 June, Edinburgh, UK), Renal Interventions spoke with Frank Dor (previously Imperial College Healthcare...
Healionics awarded US$1.25 million NIH grant to support commercialisation of novel...
Healionics Corporation has announced via press release that it has been awarded a US$1.25 million Small Business Innovation Research grant by the National Heart,...
More information needed for vascular access registries to be used effectively
Speaking to Renal Interventions, Maarten Snoeijs (Maastricht University Medical Centre, Maastricht, The Netherlands), discussed his presentation at the Hamburg Dialysis Access symposium (8–9 September,...
Empowering patients and deconstructing hierarchies key to building a successful multidisciplinary...
Renal Interventions reflects some unique perspectives and uncomfortable learnings from Yinhui-Lim Hartono, a resident new to the field of dialysis access, and Kathleen Rickert,...
Renal Interventions’ top 10 stories of November 2023
November was a month of demands for more vascular access (VA) training, novel technologies, and regulations, with Terry Litchfield highlighting the importance of compliance...
Shares drop for dialysis providers as Ozempic kidney failure study’s early...
In early October, Novo Nordisk announced they will stop the kidney outcomes trial FLOW at interim, after initial results and the recommendation from the...
New study reviews the survival rate of patients withdrawing from dialysis
Data that was presented at the American Society of Nephrology (ASN) Kidney Week meeting (2–5 November 2023, Philadelphia, USA) shows that patients who have...
AI could help predict complications in dialysis treatments, according to new...
A new study abstract from the University of Louisville, led by Adam E Gaweda (University of Louisville Health Sciences Center, Louisville, USA), was presented...
Invizius appoints nephrologist Bernard Canaud to its clinical advisory board
Invizius, a biotechnology company developing treatments for patients on dialysis, announced today the appointment of Bernard Canaud to its clinical advisory board.
Canaud brings with...
First patient treated with new renal cancer drug for dialysis patients
Oncorena announces first patient treated in the Phase I/II trial of the first-in-class compound, ONC175 (orellanine), in patients with metastatic renal cancer and dialysis....
Central venous occlusion in haemodialysis patients treated with venous stent at...
Complications such as central venous occlusion (CVO) and stenoses are among the “challenging” issues that can occur in haemodialysis patients. Now, a group of...
Artificial kidney breakthrough as bioreactor survives in pig model without immune...
Scientists at the University of California San Francisco (UCSF) are working on a new approach to treating kidney failure that could one day free...
Renal Interventions 9 – US
Highlights
Patient perspectives highlighted in conversation with representatives Vivian Papageorgiou and Phil West.
Endo Vascular Access Meeting 2023 (EVA; 23–24 June, Patras, Greece) coverage...
Renal Interventions 9 – EU
Highlights
Patient perspectives highlighted in conversation with representatives Vivian Papageorgiou and Phil West.
Endo Vascular Access Meeting 2023 (EVA; 23–24 June, Patras, Greece) coverage...
“Take time to connect”: Patient perspectives and mental impact in the...
A renal disease diagnosis is “a shock at any age”, and its “huge impact” on the lives of patients and their families is something...
Quanta announces enrolment completion in home dialysis study
Quanta Dialysis Technologies has announced that it has completed enrolment of its Home Run study for at-home haemodialysis. The Home Run study is a...
Renal Interventions’ top 10 stories of July
July was a month of acute kidney injury (AKI) updates and regulatory shifts, with empagliflozin winning European Medicines Agency approval and the US Food...
App helps haemodialysis patients control fluid intake
“The mortality rate for haemodialysis patients,” say the authors of a new study in Kidney Medicine, “remains unacceptably high.” Identifying interdialytic weight gain (IDWG)...
Quanta receives US FDA 510(k) clearance for dialysis system
Quanta Dialysis Technologies has announced that it has received US Food and Drug Administration (FDA) 510(k) clearance for an expanded indication of the Quanta...
NHS study cuts haemodialysis carbon footprint with disinfection cycle reforms
One talk at UK Kidney Week (4–7 June, Newport, Wales) moved the conference conversation onto the subject of sustainability, with Venkata Gullapudi (Leeds Teaching...
Welsh research highlights patient reluctance towards home dialysis
Why do more patients not choose haemodialysis at home? That was the question Leah McLaughlin (Bangor University, Bangor, UK) sought to answer for the...
Pathfinder Medical and Imperial College London awarded Innovate UK Smart grant...
Pathfinder Medical has been awarded a Smart grant for a £1.1 million (US$1.4 million) project by Innovate UK, the UK's innovation agency. A press...
Personalised exercise for dialysis patients cuts hospital admission
Patients who engage in light exercise while undergoing dialysis are physically fitter and are admitted to hospital less frequently than those who do not....
Daily dialysis cuts cardiovascular risk over three times weekly, finds study
Conventional haemodialysis (CHD) consists of three four-hour sessions a week, but a more regular daily haemodialysis (DHD) regimen of six three-hour sessions a week...
Earlier dialysis, transplantation show little benefit for young kidney patients
Published in the Clinical Journal of the American Society of Nephrology (CJASN), a new report has examined the timing of initiation of kidney replacement...
New data shared on ferric citrate for dialysis patients
Akebia Therapeutics has announced topline results from IMPACT, a phase 4 collaborative study investigating the impact of Auryxia (ferric citrate) when used as the...
Cognitive therapy found to cut dialysis side effect burden
A new patient-guided intervention using telemedicine to treat the side effects of dialysis including fatigue and depression has delivered “results that persist for several...
Invizius announces ‘angry blood’ haemodialysis study and recruits 300th patient
Invizius, a biotechnology company developing second generation therapies for a range of complement-driven autoimmune and inflammatory disorders, has announced that it has recruited its...
Merit Medical announces series of dialysis catheter acquisitions
Merit Medical Systems has announced that it has completed the acquisition of a portfolio of dialysis catheter products and the BioSentry biopsy tract sealant...
Renal Interventions’ top 10 stories of May 2023
May saw comprehensive coverage of the 2023 Charing Cross Symposium (CX 2023; 25–27 April, London, UK), with deep dives into cost effectiveness and endovascular...
Weight gain in long dialysis intervals heightens mortality risk
A new retrospective cohort analysis published in Hemodialysis International has found that dialysis patients who gain weight in long intervals between dialysis sessions risk...
How effective is cost effectiveness for dialysis patients?
Attendees at the 2023 Charing Cross (CX) Symposium (25–27 April, London, UK) renal interventions session were treated to two presentations exploring the issue of...
Aligning incentives to improve patient outcomes
Care of patients with chronic kidney disease (CKD) and end-stage kidney disease (ESKD) is complex, involving many decisions that are not exclusively based upon...
Renal Interventions’ top 10 stories of April 2023
April was a month of dialysis analysis and AVF updates, with end-stage renal disease (ESRD) also associated with adverse limb events in a new...
CX 2023: Peritoneal dialysis underutilised “across the world” despite advantages
Peritoneal dialysis (PD) has a number of advantages over haemodialysis—yet with a few exceptions, it is underutilised in most countries. So went the argument...
Renal Interventions 7 – EU
Highlights
First-in-human study of a regenerative material for dialysis access demonstrates initial safety and mechanical durability.
Interventional nephrology's place in kidney care explored following...
CX 2023: First-in-human study update indicates “excellent” patency results with restorative...
In a Podium First presentation during the vascular access masterclass at Charing Cross (CX) Symposium 2023 (25–27 April, London, UK), Frans Moll (University Medical...
Thrombosis focus and dialysis discussion at first CX renal interventions session
The renal interventions session at Charing Cross (CX) Symposium 2023 (25–27 April, London, UK) yielded a rich vein of education and audience participation on...
Anaemia drug Vafseo approved for treatment of dialysis patients
Akebia Therapeutics has announced that the European Commission (EC) has granted marketing authorisation for Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor...
Minimum staffing ratios fail to improve dialysis outcomes
A new study published in Hemodialysis International has found that minimum staffing regulations for haemodialysis facilities may not be associated with improved patient outcomes....
Over half of dialysis technicians report burnout in US survey
Work exhaustion and a lack of fulfilment are driving burnout among US dialysis patient care technicians (PCTs), according to a new survey whose results...
“Urgently deliver” pre-emptive living donor kidney transplantation “as the default”
Living-donor kidney transplantation should be “treatment of choice” over deceased-donor transplantation, owing to it being the “most secure way to achieve pre-emptive kidney transplantation”....
All-cause mortality higher, CVD deaths lower for female dialysis patients
A new retrospective cohort study published in the American Journal of Kidney Diseases (AJKD) has found that women are more likely to die from...
“We need to come out of our silos”: Surgical education urged...
In one of the select presentations at the American Society of Diagnostic and Interventional Nephrology (ASDIN) 19th Annual Scientific Meeting (17–19 February, Orlando, USA)...
Study suggests Black patients more prone to dialysis graft failure
Compared to other races, African American patients are more likely to experience premature arteriovenous (AV) graft failure in the treatment of advanced kidney failure,...
PAIRS previewed and EVA reviewed in assessment of access for dialysis
Looking ahead to the upcoming Pan Arab Interventional Radiological Society meeting (PAIRS, 11–14 February, Dubai, UAE), Karim Abdel Tawab (Ain Shams University, Cairo, Egypt)...
Vasc-Alert shares new data endorsing its vascular access blockage prediction technology
Vasc-Alert, a pioneer in vascular access surveillance, has announced the publication of a study in the Journal of Vascular Access (JVA) validating its Vasc-Alert...
Early plan for “crash-landers” during tunnelled dialysis catheter placement crucial
The fourth annual Hamburg Dialysis Access Symposium (23–24 September, Hamburg, Germany) was recently organised and moderated by Robert Shahverdyan (Asklepios Clinic Barmbek, Hamburg, Germany),...
Music during cannulation cuts patient pain, study claims
Eight minutes of Mozart have been found to reduce the pain of cannulation for haemodialysis patients, though not their level of anxiety, in a...
Ultrasound an “objective adjunct” for cannulation that can improve outcomes and...
Ultrasound is a powerful tool for assessing haemodialysis (HD) access for maturity, but may also be used to guide HD access cannulations and has...
Digital dialysis device from liberDi receives FDA approval
liberDi announced today that it has received regulatory clearance from the US Food and Drug Administration (FDA) for its digital dialysis clinic, which allows...
Holly implantable dialysis device’s offer of increased patient freedom outlined
Dirk M Hentschel (Harvard Medical School, Cambridge, USA), president of the Vascular Access Society of the Americas (VASA), has presented on the new Nephrodite...
Renalytix share new data suggesting their KidneyIntelX bioprognostic test improves decision-making
Renalytix has announced the publication of new real-world evidence in Primary Care and Community Health demonstrating the company’s KidneyIntelX bioprognostic test resulted in changed clinical decision-making for patients...
Higher risk of all-cause mortality found in female patients after starting...
Compared with male patients, female patients have been found to have a higher risk of all-cause mortality in the first five years post-dialysis initiation—a...
Conservative management better than dialysis for some advanced kidney disease patients
For some individuals with advanced kidney disease, dialysis may not be the optimal treatment strategy for their condition, and these patients may be better...
Urgent dialysis during hospitalisation for surgery linked to poorer outcomes
Researchers from Tokyo Medical and Dental University (TMDU) in Tokyo, Japan have found that a need for emergency dialysis during hospitalisation for surgery is...
Multidisciplinary community unites at inaugural patient-focused ESKD Summit
This advertorial, sponsored by BD, is only available in selected countries and geographies.
“The Changing Face of a Dialysis Patient” was the central theme...
Fresenius Medical Care launches Speedswap to optimise dialysis in acute care...
Fresenius Medical Care North America's (FMCNA) Renal Therapies Group recently announced the availability of Speedswap—a new option for the company’s NxStage System One with NxView that enables the...
Gore acquires InnAVasc Medical
Gore has announced the acquisition of InnAVasc Medical, a privately held medical technology company focused on advancing care for patients with end-stage renal disease...
Fresenius Medical Care North America introduces first single-use integrated bloodline to...
Fresenius Medical Care North America's (FMCNA) Renal Therapies Group recently announced the availability of the CombiSet Smartech. According to a company press release, this...
Intraoperative vascular mapping during haemodialysis access “should be incorporated into routine...
Intraoperative ultrasonographic venous mapping is a useful tool to evaluate vessel suitability for arteriovenous fistula (AVF) creation, Yana Etkin (Zucker School of Medicine at...
UK study striving to Inter-CEPt home dialysis discrepancies before they become...
As highlighted by previous studies, as well as the Getting It Right First Time (GIRFT) national report on renal medicine and data from the...
UK Renal Registry annual report reveals uptick in peritoneal dialysis amidst...
James Medcalf (Leicester, UK), UK Renal Registry medical director, tells Renal Interventions at UK Kidney Week (UKKW 2022; 7–9 June, Birmingham, UK), “This year...
VentureMed completes enrolment of Flex Vessel Prep system randomised controlled trial...
VentureMed Group recently announced that it has completed enrolment of a randomised controlled trial (RCT) titled 'Flex Vessel Prep prior to PTA for the...
Dialyze Direct publishes data indicating rapid recovery times following more frequent...
Dialyze Direct has announced that its findings regarding the effect of more frequent dialysis for end-stage kidney disease (ESKD) patients in skilled nursing facilities...
Houston, we have a dialysis access problem
The concept of dedicated vascular access centres fuels a turbocharged Texan tussle with Karl Illig (Flow Vascular Center, Houston, USA) taking on Eric Peden...
Retransplantation may offer greater survival outcomes than dialysis following a failed...
As per a clinical study involving more than 2,300 adult patients, a second kidney transplant is likely to offer improved survival outcomes when compared...
US researchers develop methods to improve patient screening for compassionate dialysis
Screening protocols to determine who qualifies for ‘compassionate dialysis’ in hospitals with high numbers of uninsured patients are contributing to increased strain on the...
Dialyss Pte Limited acquired by NextKidney BV
NextKidney BV has announced the acquisition of Dialyss Pte Limited from 1 January 2022. According to a press release, this marks a major milestone...
Dialysis tech firm Pathfinder Medical secures £8.5 million
Pathfinder Medical, which has developed a proprietary technology to guide and accurately align catheters in endovascular procedures allowing clinicians to make connections across blood...
New company Anais Medical to bring high-realism simulation for interventional procedures...
Anais Medical, a new company founded by Parc Taulí Research and Innovation Institute (I3PT) and led by José Ibeas (nephrologist at Parc Taulí University...
Fresenius and Biim to expand usage of portable ultrasound system for...
Fresenius Kidney Care and Biim Ultrasound AS have announced an agreement to expand use of Biim's innovative ultrasound system for assisting needle cannulation prior to dialysis...
DaVita announces its North American operations are now powered by 100%...
DaVita has recently become the first kidney care provider to completely power its North American operations with renewable energy, according to a press release...
Alio and Lifeline create partnership for dialysis access patient monitoring
Alio has announced a partnership with Lifeline Vascular Care in support of patients living with end-stage renal disease (ESRD). Alio leverages artificial intelligence (AI)...
DaVita Clinical Research study indicates mRNA COVID-19 vaccines effective in dialysis...
Dialysis patients who received mRNA COVID-19 vaccines had a lower risk of COVID-19 diagnosis post-vaccination, and were less likely to be hospitalised or die...
Improved understanding of current dialysis modalities may hold greater value than...
There are several different types of dialysis treatment available to kidney disease patients—with the three major players, in-centre haemodialysis (ICHD), home haemodialysis (HHD) and...
Baxter launches My Kidney Journey portal to support kidney disease patients...
Baxter Asia Pacific (Baxter) has announced the launch of My Kidney Journey—a comprehensive online portal intended to support patients living with chronic kidney disease (CKD) in the Asia...
Outset Medical gains landmark CMS approval for Tablo home haemodialysis system
Outset Medical has announced that its Tablo haemodialysis system has received the first ever approval from the Centers for Medicare & Medicaid Services (CMS) for...
New survey finds one third of UK dialysis patients still not...
Quanta Dialysis Technologies announced today the results of the UK Dialysis Patient Experience Survey, showing the wide variance in care experienced by UK dialysis...
Stable incidence and survival of AVFs seen in long-term study of...
Despite an older dialysis population, the proportion and survival of arteriovenous fistulas (AVFs) in Danish dialysis patients has not changed over a 39-year period....
Fresenius Medical Care North America announces three key clinical leadership appointments
Fresenius Medical Care North America (FMCNA) has announced three key clinical leadership appointments to help drive priorities, including improving patient outcomes, adopting connected health technologies...
The WavelinQ™ EndoAVF System takes an innovative approach in creating endovascular...
NOTE: This advertorial is ONLY available to watch in selected countries and geographies
This advertorial, sponsored by BD, is intended for readers in the...
ImpediMed gains FDA Breakthrough Device designation for digital renal failure platform
ImpediMed, an Australia-based medical technology company using bioimpedance spectroscopy (BIS) to generate powerful data to improve patient health, has announced that the Sozo digital...
Baxter collaborating with AWS to enhance “digital transformation” of dialysis portfolio
Through collaboration with Amazon Web Services (AWS), Baxter International is using cloud technology solutions to accelerate its company-wide digital transformation. According to a Baxter...
NKF publishes recommendations to move thousands of patients from dialysis to...
The National Kidney Foundation (NKF) has released a position paper, developed by 16 nephrology experts from 13 institutions, with recommendations designed to navigate future research...
Fresenius expands UK renal services with five-year Polar Speed agreement
Polar Speed—UPS Healthcare's UK operation—has announced a five-year commercial agreement with Fresenius Medical Care to provide warehouse and transport solutions for the delivery of...
Diaverum launches 2021 travel guide for dialysis patients
Diaverum, a global renal care service provider, has launched its first ever holiday dialysis travel guide in an effort to “empower renal patients worldwide...
Virtual support groups create community for DaVita home dialysis patients
DaVita Kidney Care has launched virtual support groups through DaVita Care Connect, a mobile health platform designed for home dialysis patients, which the company...
US kidney care coalition announces major initiative to develop quality metrics...
Kidney Care Partners (KCP)—a US multi-stakeholder coalition representing patient advocates, physician organisations, health professional groups, dialysis providers, researchers and manufacturers—has relaunched the Kidney Care...
Further enhancements required to optimise artificial kidney device for peritoneal dialysis...
Despite the device demonstrating no serious adverse events (SAEs) in a preliminary safety study, researchers believe further enhancements are needed to improve the outcomes...
Higher kidney transplant referral rates found in non-profit dialysis facilities versus...
New research indicates that patients with kidney failure who receive care at for-profit dialysis facilities are less likely to be referred for kidney transplants...
US Renal Care distributes second round of COVID-19 vaccines to dialysis...
Dialysis provider US Renal Care recently announced it has finished administering a second round of mRNA vaccines to ensure better protection against COVID-19 for...
Balloon angioplasty in critical time window central to endovascular success for...
Tackling the main culprit, stenosis in the arteriovenous anastomosis and outflow veins, with balloon angioplasty before it is “too late” can boost maturation rates...
Fresenius Medical Care makes dialysis clinics available for COVID-19 vaccination
Fresenius Medical Care has made its own dialysis clinics available for the vaccination of its patients against COVID-19.
Dialysis patients are an especially high-risk group...
Algorithm predicts dialysis, and death from critical illness in hospitalised COVID-19...
Acute kidney injury (AKI) treated with dialysis is reported to be a frequent complication in patients hospitalised with COVID-19. Research published online in the...
Study provides new insights on COVID-19 risk in patients receiving dialysis
Many individuals with kidney failure have been unable to self-isolate during the COVID-19 pandemic because they require dialysis treatments in clinics several times a...
Early-cannulation grafts display parity with ePTFE options—but also face similar challenges
In addition to demonstrating comparable performance in terms of long-term patency, durability and associated complications, early-cannulation arteriovenous (AV) grafts may hold some advantages when...
More mixed results for DCBs in AV access maintenance as evidence...
Additional randomised controlled data regarding the effectiveness of drug-coated balloons (DCBs) in maintaining arteriovenous (AV) access offers new evidence, but it is freighted with...
Fresenius Medical Care introduces Kinexus connected health platform for home dialysis
Through its Renal Therapies Group, Fresenius Medical Care North America (FMCNA) has introduced the Kinexus Therapy Management Platform—a new connected health platform for home...
Baxter gains FDA clearance for next-generation AK 98 dialysis machine
American healthcare firm and global renal care innovator Baxter International has announced US Food and Drug Administration (FDA) 510(k) clearance of its next-generation Artificial...
High-flow fistulas remain divisive, with uncertainty over reduction and outcomes
Discussions at this year’s Charing Cross (CX) 2021 Digital Edition (19–22 April, online) indicated that high-flow arteriovenous (AV) fistulas remain one of the more...
Invizius raises £5.3 million to assess anti-inflammatory treatment for haemodialysis patients
Invizius has announced the closing of a Series A financing round worth £5.3 million. The Scottish biotechnology company will use this funding to complete...
Wearable device for AV fistula remote monitoring shows promise—but faces commercial...
A new wearable device designed to remotely monitor arteriovenous (AV) fistulae function in dialysis access patients uncovered promising data leading one set of researchers...
Ultrasound guidance shown to improve cannulation accuracy, particularly in harder-to-needle AV...
A small, randomised trial conducted in a UK dialysis unit has found that ultrasound guidance can improve cannulation accuracy—and this improvement may be most...
Fresenius and DaVita make home dialysis technologies available to patients across...
Fresenius Medical Care North America and DaVita Kidney Care have announced an expanded agreement to make multiple home dialysis technologies available for patients across...
Renal artery involvement in EVAR linked to permanent dialysis and lower...
Renal artery involvement (RAI) in endovascular aneurysm repair (EVAR) is “highly predictive of the need for postoperative and permanent dialysis,” Anastasia Plotkin (University of...